|
|
|
|
|
(State or other jurisdiction of incorporation or organization
|
(I.R.S. Employer Identification No.)
|
|
|
|
|
|
(Address of principal executive offices, including zip code)
|
|
Title of each class
|
Trading Symbol(s)
|
Name of each exchange on which registered
|
|
None
|
N/A
|
N/A
|
|
Large accelerated filer ☐
|
Accelerated filer
|
☐
|
||
|
|
Smaller reporting company
|
|
Emerging growth company
|
|
Page
|
|||
|
PART I. FINANCIAL INFORMATION
|
|||
|
Item 1.
|
Financial Statements
|
||
|
2
|
|||
|
3
|
|||
| Condensed Statements of Operations for the Nine Months Ended September 30, 2021 and 2020 (Unaudited) | 4 |
||
| 5 |
|||
| Condensed Statements of Stockholders’ Equity for the Nine Months Ended September 30, 2021 and 2020 (Unaudited) | 6 |
||
| 7 |
|||
| 8 |
|||
|
Item 2.
|
12 |
||
|
Item 4.
|
17 | ||
|
PART II. OTHER INFORMATION
|
|||
|
Item 6.
|
18
|
||
|
19
|
|||
|
Item 1.
|
Financial Statements
|
|
September 30,
2021
|
December 31,
2020
|
|||||||
|
(Unaudited)
|
(Note 1)
|
|||||||
|
ASSETS
|
||||||||
|
Current assets:
|
||||||||
|
Cash and cash equivalents
|
$
|
|
$
|
|
||||
|
Available-for-sale securities – municipal bonds
|
|
|
||||||
|
Accounts receivable, net of allowance of $
|
|
|
||||||
|
Other current assets
|
|
|
||||||
|
Total current assets
|
|
|
||||||
|
Property and equipment, net
|
|
|
||||||
|
Operating lease right-to-use asset
|
|
|
||||||
|
Goodwill
|
|
|
||||||
|
Other assets
|
|
|
||||||
|
Total assets
|
$
|
|
$
|
|
||||
|
LIABILITIES AND STOCKHOLDERS’ EQUITY
|
||||||||
|
Current liabilities:
|
||||||||
|
Unexpired subscription revenue
|
$
|
|
$
|
|
||||
|
Accounts payable
|
|
|
||||||
|
Current portion of operating lease liability
|
|
|
||||||
|
Current portion of bank loan
|
|
|
||||||
|
Accrued expenses
|
|
|
||||||
|
Total current liabilities
|
|
|
||||||
|
Deferred taxes on income, net
|
|
|
||||||
|
Unexpired subscription revenue, less current portion
|
|
|
||||||
|
Bank loan, less current portion
|
|
|
||||||
|
Operating lease liability, less current portion
|
|
|
||||||
|
Total liabilities
|
|
|
||||||
|
Stockholders’ equity:
|
||||||||
|
Preferred stock, $
|
|
|
||||||
|
Common stock, $
|
|
|
||||||
|
Additional paid-in capital
|
|
|
||||||
|
Accumulated deficit
|
(
|
)
|
(
|
)
|
||||
|
Total stockholders’ equity
|
|
|
||||||
|
Total liabilities and stockholders’ equity
|
$
|
|
$
|
|
||||
|
2021
|
2020
|
|||||||
|
Operating revenues
|
$
|
|
$
|
|
||||
|
Operating expenses:
|
||||||||
|
Data and product costs
|
|
|
||||||
|
Selling, general and administrative expenses
|
|
|
||||||
|
Depreciation and amortization
|
|
|
||||||
|
Total operating expenses
|
|
|
||||||
|
Income from operations
|
|
|
||||||
|
Other income
|
|
|
||||||
|
Income before income taxes
|
|
|
||||||
|
Provision for income taxes
|
(
|
)
|
(
|
)
|
||||
|
Net income
|
$
|
|
$
|
|
||||
|
Net income per share – Basic and diluted
|
$
|
|
$
|
|
||||
|
Weighted average number of common shares outstanding –
|
||||||||
|
Basic
|
|
|
||||||
|
Diluted
|
|
|
||||||
|
2021
|
2020
|
|||||||
|
Operating revenues
|
$
|
|
$
|
|
||||
|
Operating expenses:
|
||||||||
|
Data and product costs
|
|
|
||||||
|
Selling, general and administrative expenses
|
|
|
||||||
|
Depreciation and amortization
|
|
|
||||||
|
Total operating expenses
|
|
|
||||||
|
Income (loss) from operations
|
|
(
|
)
|
|||||
|
Other income
|
|
|
||||||
|
Income (loss) before income taxes
|
|
(
|
)
|
|||||
|
(Provision for) benefit from income taxes
|
(
|
)
|
|
|||||
|
Net income
|
$
|
|
$
|
|
||||
|
Net income per share – Basic and diluted
|
$ |
$
|
|
|||||
|
Weighted average number of common shares outstanding –
|
||||||||
|
Basic
|
|
|
||||||
|
Diluted
|
|
|
||||||
| Additional |
Total
|
|||||||||||||||||||
| Common Stock |
Paid-in
Capital
|
Accumulated
Deficit
|
Stockholders' Equity
|
|||||||||||||||||
|
Shares
|
Amount
|
|||||||||||||||||||
|
Balance July 1, 2020
|
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
|
||||||||||
|
Net income
|
-
|
|
|
|
|
|||||||||||||||
|
Stock-based compensation
|
-
|
|
|
|
|
|||||||||||||||
|
Balance September 30, 2020
|
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
|
||||||||||
|
Balance July 1, 2021
|
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
|
||||||||||
|
Net income
|
-
|
|
|
|
|
|||||||||||||||
|
Stock-based compensation
|
-
|
|
|
|
|
|||||||||||||||
|
Balance September 30, 2021
|
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
|
||||||||||
| Additional | Total | |||||||||||||||||||
|
Common Stock
|
Paid-in
Capital
|
Accumulated
Deficit
|
Stockholders’
Equity
|
|||||||||||||||||
|
Shares
|
Amount
|
|||||||||||||||||||
|
Balance January 1, 2020
|
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
|
||||||||||
|
Net income
|
-
|
|
|
|
|
|||||||||||||||
|
Stock-based compensation
|
-
|
|
|
|
|
|||||||||||||||
|
Balance September 30, 2020
|
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
|
||||||||||
|
Balance January 1, 2021
|
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
|
||||||||||
|
Net income
|
-
|
|
|
|
|
|||||||||||||||
|
Stock-based compensation
|
-
|
|
|
|
|
|||||||||||||||
|
Balance September 30, 2021
|
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
|
||||||||||
|
2021
|
2020
|
|||||||
|
Cash flows from operating activities:
|
||||||||
|
Net income
|
$
|
|
$
|
|
||||
|
Adjustments to reconcile net income to net cash
|
||||||||
| provided by operating activities: | ||||||||
|
Deferred income taxes
|
|
(
|
)
|
|||||
|
Depreciation and amortization
|
|
|
||||||
|
Operating lease right-to-use asset, net
|
|
|
||||||
|
Stock-based compensation
|
|
|
||||||
|
Changes in operating assets and liabilities:
|
||||||||
|
Accounts receivable
|
|
|
||||||
|
Other current assets
|
|
(
|
)
|
|||||
|
Other assets
|
|
(
|
)
|
|||||
|
Unexpired subscription revenue
|
(
|
)
|
|
|||||
|
Accounts payable
|
(
|
)
|
(
|
)
|
||||
|
Accrued expenses
|
(
|
)
|
(
|
)
|
||||
|
Net cash provided by operating activities
|
|
|
||||||
|
Cash flows from investing activities:
|
||||||||
|
Sale of available-for-sale securities – municipal bonds
|
|
|
||||||
|
Purchase of property and equipment
|
(
|
)
|
(
|
)
|
||||
|
Net cash provided by (used in) investing activities
|
|
(
|
)
|
|||||
| Cash flows from financing activities: |
||||||||
|
Proceeds from bank loan
|
||||||||
| Net cash provided by financing activities |
||||||||
|
Net increase in cash and cash equivalents
|
|
|
||||||
|
Cash and cash equivalents at beginning of period
|
|
|
||||||
|
Cash and cash equivalents at end of period
|
$
|
|
$
|
|
||||
|
3 Months Ended
September 30,
|
9 Months Ended
September 30,
|
|||||||||||||||
|
2021
|
2020
|
2021
|
2020
|
|||||||||||||
|
Data and product costs
|
$ |
|
$ |
|
$ |
|
$ |
|
||||||||
|
Selling, general and administrative expenses
|
|
|
|
|
||||||||||||
| $ |
|
$ |
|
$ |
|
$ |
|
|||||||||
|
September 30, 2021
|
||||||||||||||||
|
Level 1
|
Level 2
|
Level 3
|
Total
|
|||||||||||||
|
Cash and cash equivalents
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
|
December 31, 2020
|
||||||||||||||||
|
Level 1
|
Level 2
|
Level 3
|
Total
|
|||||||||||||
|
Cash and cash equivalents
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
|
Available-for-sale securities
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
|
3 Months Ended
September 30,
|
9 Months Ended
September 30,
|
|||||||||||||||
|
2021
|
2020
|
2021
|
2020
|
|||||||||||||
|
Weighted average number of common shares outstanding – basic
|
|
|
|
|
||||||||||||
|
Potential shares exercisable under stock option plans
|
|
|
|
|
||||||||||||
| LESS: Shares which could be repurchased under treasury stock method | ( |
) | ( |
) | ( |
) | ( |
) | ||||||||
|
Weighted average number of common shares outstanding – diluted
|
|
|
|
|
||||||||||||
| Item 2. |
Management’s Discussion and Analysis of Financial Condition and Results of Operations
|
|
September 30,
2021
|
December 31,
2020
|
|||||||
|
Cash and cash equivalents
|
$
|
11,694
|
$
|
10,303
|
||||
|
Accounts receivable, net
|
$
|
2,273
|
$
|
2,557
|
||||
|
Working capital
|
$
|
1,593
|
$
|
848
|
||||
|
Cash ratio
|
0.91
|
0.79
|
||||||
|
Quick ratio
|
1.09
|
0.98
|
||||||
|
Current ratio
|
1.12
|
1.06
|
||||||
|
3 Months Ended September 30,
|
||||||||||||||||
|
2021
|
2020
|
|||||||||||||||
|
Amount
|
% of Total
Operating
Revenues
|
Amount
|
% of Total
Operating
Revenues
|
|||||||||||||
|
Operating revenues
|
$
|
4,323,676
|
100
|
%
|
$
|
4,037,456
|
100
|
%
|
||||||||
|
Operating expenses:
|
||||||||||||||||
|
Data and product costs
|
1,519,860
|
35
|
%
|
1,514,659
|
38
|
%
|
||||||||||
|
Selling, general and administrative expenses
|
2,024,562
|
47
|
%
|
2,110,280
|
52
|
%
|
||||||||||
|
Depreciation and amortization
|
75,067
|
2
|
%
|
52,931
|
1
|
%
|
||||||||||
|
Total operating expenses
|
3,619,489
|
84
|
%
|
3,677,870
|
91
|
%
|
||||||||||
|
Income from operations
|
704,187
|
16
|
%
|
359,586
|
9
|
%
|
||||||||||
|
Other income, net
|
263
|
0
|
%
|
916
|
0
|
%
|
||||||||||
|
Income before income taxes
|
704,450
|
16
|
%
|
360,502
|
9
|
%
|
||||||||||
|
Provision for income taxes
|
(209,098
|
)
|
(5
|
%)
|
(79,420
|
)
|
(2
|
%)
|
||||||||
|
Net income
|
$
|
495,352
|
11
|
%
|
$
|
281,082
|
7
|
%
|
||||||||
|
9 Months Ended September 30,
|
||||||||||||||||
|
2021
|
2020
|
|||||||||||||||
|
Amount
|
% of Total
Operating
Revenues
|
Amount
|
% of Total
Operating
Revenues
|
|||||||||||||
|
Operating revenues
|
$
|
12,704,756
|
100
|
%
|
$
|
11,598,210
|
100
|
%
|
||||||||
|
Operating expenses:
|
||||||||||||||||
|
Data and product costs
|
4,721,331
|
37
|
%
|
4,556,456
|
39
|
%
|
||||||||||
|
Selling, general and administrative expenses
|
6,415,736
|
50
|
%
|
6,919,804
|
60
|
%
|
||||||||||
|
Depreciation and amortization
|
206,083
|
2
|
%
|
160,736
|
1
|
%
|
||||||||||
|
Total operating expenses
|
11,343,150
|
89
|
%
|
11,636,996
|
100
|
%
|
||||||||||
|
Income (loss) from operations
|
1,361,606
|
11
|
%
|
(38,786
|
)
|
(0
|
%)
|
|||||||||
|
Other income, net
|
3,756
|
0
|
%
|
27,017
|
0
|
%
|
||||||||||
|
Income (loss) before income taxes
|
1,365,362
|
11
|
%
|
(11,769
|
)
|
(0
|
%)
|
|||||||||
|
(Provision for) benefit from income taxes
|
(359,588
|
)
|
(3
|
%)
|
123,424
|
1
|
%
|
|||||||||
|
Net income
|
$
|
1,005,774
|
8
|
%
|
$
|
111,655
|
1
|
%
|
||||||||
| Item 4. |
Controls and Procedures
|
| Item 6. |
Exhibits
|
|
Certification of Chief Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
|
||
|
Certification of Chief Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
|
||
|
Certification of Chief Executive Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
|
||
|
Certification of Chief Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
|
||
|
101.INS
|
XBRL Instance Document
|
|
|
101.SCH
|
XBRL Taxonomy Extension Schema Document
|
|
|
101.CAL
|
XBRL Taxonomy Extension Calculation Linkbase Document
|
|
|
101.DEF
|
XBRL Taxonomy Extension Definition Linkbase Document
|
|
|
101.LAB
|
XBRL Taxonomy Extension Label Linkbase Document
|
|
|
101.PRE
|
XBRL Taxonomy Extension Presentation Linkbase Document
|
|
CREDITRISKMONITOR.COM, INC.
|
|||
|
(REGISTRANT)
|
|||
|
Date: November 12, 2021
|
By:
|
/s/
|
Steven Gargano
|
|
Steven Gargano
|
|||
|
Senior Vice President & Chief Financial Officer
|
|||
|
(Principal Finance and Accounting Officer)
|
|||